Stateside researchers working in the fightback against cancer have said that vaccines which shrink tumours and prevent them from returning may be available in as little as five years time. Following on from decades of trialling and testing to no avail, scientists say that their research has reached a turning point.
And while the shots are being called vaccines, they don't work in the same vein as traditional boosters which prevent diseases. Instead, they shrink tumours and stop them from returning to the affected site.
Breast and lung cancer are types of the disease which are being targeted by the experimental treatment - with gains also reported in 2023 for melanoma and pancreatic cancers. Volunteer patients have said that they are participating in the trials not only with hopes of shrinking their own tumours, but to also help those in future who suffer the devastating disease.
